Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-06-26

FDA Approved: CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved an original application for a generic product combining clindamycin phosphate and benzoyl peroxide for topical treatment of acne vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clindamycin Phosphate and Benzoyl Peroxide (clindamycin phosphate and benzoyl peroxide)

Snippet

ORIG AP for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE (CLINDAMYCIN, BENZOYL PEROXIDE)